The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: An Intermediate Expanded Use Trial of DFMO
Official Title: An Intermediate Expanded Use Trial of DFMO
Study ID: NCT03581240
Brief Summary: To provide DFMO in an expanded use setting to subjects with relapsed rare tumors with increased LIN28 expression or MYCN amplification or up regulation of ornithine decarboxylase.
Detailed Description:
Minimum Age: 0 Years
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey, Pennsylvania, United States
Name: Giselle Sholler, MD
Affiliation: Beat Childhood Cancer
Role: STUDY_CHAIR